BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27895483)

  • 1. Improved proliferation of antigen-specific cytolytic T lymphocytes using a multimodal nanovaccine.
    Li B; Siuta M; Bright V; Koktysh D; Matlock BK; Dumas ME; Zhu M; Holt A; Stec D; Deng S; Savage PB; Joyce S; Pham W
    Int J Nanomedicine; 2016; 11():6103-6121. PubMed ID: 27895483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.
    Hamdy S; Haddadi A; Shayeganpour A; Samuel J; Lavasanifar A
    Pharm Res; 2011 Sep; 28(9):2288-301. PubMed ID: 21560020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 6. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response.
    Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D
    Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.
    Bailey BA; Desai KH; Ochyl LJ; Ciotti SM; Moon JJ; Schwendeman SP
    Mol Pharm; 2017 Sep; 14(9):3228-3237. PubMed ID: 28726424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection.
    Tallapaka SB; Karuturi BVK; Yeapuri P; Curran SM; Sonawane YA; Phillips JA; David Smith D; Sanderson SD; Vetro JA
    Int J Pharm; 2019 Jun; 565():242-257. PubMed ID: 31077762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines.
    Xu P; Tang S; Jiang L; Yang L; Zhang D; Feng S; Zhao T; Dong Y; He W; Wang R; Zhang J; Liang Z
    J Control Release; 2016 Mar; 225():252-68. PubMed ID: 26826303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
    Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
    Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses.
    Liu Q; Jia J; Yang T; Fan Q; Wang L; Ma G
    Small; 2016 Apr; 12(13):1744-57. PubMed ID: 26849717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine.
    Han S; Ma W; Jiang D; Sutherlin L; Zhang J; Lu Y; Huo N; Chen Z; Engle JW; Wang Y; Xu X; Kang L; Cai W; Wang L
    J Nanobiotechnology; 2021 Nov; 19(1):394. PubMed ID: 34838057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses.
    Liu L; Cao F; Liu X; Wang H; Zhang C; Sun H; Wang C; Leng X; Song C; Kong D; Ma G
    ACS Appl Mater Interfaces; 2016 May; 8(19):11969-79. PubMed ID: 27088457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
    Ko SY; Ko HJ; Chang WS; Park SH; Kweon MN; Kang CY
    J Immunol; 2005 Sep; 175(5):3309-17. PubMed ID: 16116223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
    Han HD; Byeon Y; Kang TH; Jung ID; Lee JW; Shin BC; Lee YJ; Sood AK; Park YM
    Int J Nanomedicine; 2016; 11():5729-5742. PubMed ID: 27843314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.